Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024

SELL
$151.44 - $200.09 $3.38 Million - $4.46 Million
-22,290 Closed
0 $0
Q1 2022

May 05, 2022

SELL
$181.39 - $234.03 $14.7 Million - $19 Million
-81,127 Reduced 78.45%
22,290 $4.2 Million
Q4 2021

Feb 02, 2022

BUY
$193.69 - $247.03 $6.29 Million - $8.03 Million
32,500 Added 45.83%
103,417 $21.7 Million
Q3 2021

Nov 12, 2021

BUY
$189.29 - $209.69 $13.4 Million - $14.9 Million
70,917 New
70,917 $13.8 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $83.7B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Smith Group Asset Management, LLC Portfolio

Follow Smith Group Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Smith Group Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Smith Group Asset Management, LLC with notifications on news.